Arcadia Biosciences (RKDA) analyst forecast and price target
Analyst forecast
Consensus of 1 analyst rating
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $6.00 | Aug 21, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 from $10.00 | May 23, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | Apr 5, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 from $15.00 | Aug 28, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 | Jul 24, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $15.00 from $18.00 | Jun 5, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 from $3.00 | Apr 14, 2023 |
Frequently asked questions
Is RKDA a buy, sell, or hold?
Analysts covering Arcadia Biosciences currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on RKDA?
On Aug 21, 2024, HC Wainwright & Co. maintained Arcadia Biosciences at Buy with a price target of $6.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.